Literature DB >> 8598094

Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry.

D H Chace1, S L Hillman, D S Millington, S G Kahler, B W Adam, H L Levy.   

Abstract

We report a new method for the diagnosis of homocystinuria and other hypermethioninemias from dried blood spots on newborn screening cards, based on isotope-dilution tandem mass spectrometry. The mean concentration of methionine in 909 unaffected newborns was 19 micromol/L (CV 44%). The variability of results was reduced when the concentration of methionine was expressed relative to that of another amino acid in the same specimen. The mean ratio of methionine to leucine plus isoleucine for these same newborn blood spots was 0.16 (CV 25%). In newborn samples from a collection categorized by a Guthrie bacterial inhibition assay as true positive, unaffected, or falsely positive for hypermethioninemias, the ratio of methionine to leucine for each true-positive specimen was at least 2.5 times greater than for respective age-matched unaffected blood specimens. The ratio for falsely positive samples did not differ from that for unaffected blood samples. We predict that the ratio of methionine to leucine plus isoleucine determined by tandem mass spectrometry will successfully detect hypermethioninemias with very low rates for false positives and false negatives.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598094

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

Review 1.  Population newborn screening for inherited metabolic disease: current UK perspectives.

Authors:  A Green; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 2.  Tandem mass spectrometry--the potential.

Authors:  K Bartlett; M Pourfarzam
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 3.  Newborn Screening for Lysosomal Storage Disorders.

Authors:  Roy W A Peake; Olaf A Bodamer
Journal:  J Pediatr Genet       Date:  2016-12-02

4.  Differentiation and quantification of C1 and C2 (13)C-labeled glucose by tandem mass spectrometry.

Authors:  Wei Jiang; Vicki H Wysocki; Eric D Dodds; Roger L Miesfeld; Patricia Y Scaraffia
Journal:  Anal Biochem       Date:  2010-05-04       Impact factor: 3.365

5.  Fragmentation pathway for glutamine identification: loss of 73 Da from dimethylformamidine glutamine isobutyl ester.

Authors:  Qingfen Zhang; Vicki H Wysocki; Patricia Y Scaraffia; Michael A Wells
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

6.  Study of the fragmentation of arginine isobutyl ester applied to arginine quantification in Aedes aegypti mosquito excreta.

Authors:  David R Bush; Vicki H Wysocki; Patricia Y Scaraffia
Journal:  J Mass Spectrom       Date:  2012-10       Impact factor: 1.982

7.  Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum.

Authors:  E J Quackenbush; K H Kraemer; W A Gahl; V Schirch; D A Whiteman; K Levine; H L Levy
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

8.  Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.

Authors:  Chien-Chen Lai; Chang-Hai Tsai; Fuu-Jen Tsai; Jer-Yuarn Wu; Wei-De Lin; Cheng-Chun Lee
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

9.  Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile.

Authors:  K G Sim; V Wiley; K Carpenter; B Wilcken
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

10.  Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis.

Authors:  Nicholas J Martin; Josephine Bunch; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2013-06-01       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.